Rafael Holdings Corp - Likuiditas cepet RFL

Rafael Holdings, Inc. (RFL) focuses on acquiring promising medical facilities and biopharmaceutical projects to combat oncology. Asset value growth is driven by partnerships for the financing and commercial implementation of patents from early-stage startups. Current price action on GURU.Markets, where the coefficient is 2.30, is subject to biotech sector volatility and potential laboratory space vacancies.

The quick ratio measures a company's ability to meet short-term obligations using its most liquid assets, completely excluding inventory from the calculation. By analyzing this quick liquidity snapshot, an investor can see the real margin of safety for Rafael Holdings, Inc. (RFL), which is supported by stable cash flows from real estate rentals and biotech investments, ensuring the holding company's sustained financial health.